Typhoid vaccine
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Typhoid vaccine is a vaccine used to prevent typhoid.
- Brand Names
- Vivotif
- Generic Name
- Typhoid vaccine
- DrugBank Accession Number
- DB14022
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Other vaccines - Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Prevention of Disease caused by salmonella typhi •••••••••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbatacept The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Abatacept. Acetic acid The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Acetic acid. Acetyl sulfisoxazole The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Acetyl sulfisoxazole. Adalimumab The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Adalimumab. Aldesleukin The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Aldesleukin. - Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Typhoid Vaccine Suspension 1000 m / mL Subcutaneous Aventis Pasteur Limited 1973-11-30 2000-11-14 Canada Vivotif-B Capsule 2 [CFU]/1 Oral Rebel Distributors Corp 1989-12-15 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 760T5R8B3O
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- Wikipedia
- Typhoid_vaccine
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Not Yet Recruiting Prevention Monkeypox 1 4 Recruiting Basic Science Risk Reduction 1 4 Terminated Prevention Aging / Inflammation 1 3 Completed Prevention Disease caused by Salmonella typhi 1 3 Completed Prevention Hepatitis A 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Suspension Subcutaneous 1000 m / mL Capsule Oral 2 [CFU]/1 - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
Drug created at May 14, 2018 17:07 / Updated at June 12, 2020 17:42